Daisy Duan is an Endocrinology/Metabolic physician affiliated with MDS Associates. OpenAlex indexes 68 publications with 1,338 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St Bldg
1830 Bldg, Suite 333
Baltimore, MD 212870005
Telephone
410-955-3921Provider last certified this registry record 7 Jul 2021.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
- Inspire Medical Systems, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
82.3%GLP-1 receptor agonist35.5%Ozempic45%Mounjaro37%Trulicity18%Part D<11 patientsInsulin Analog26.6%Tresiba Flextouch U-10035%Novolog Flexpen27%Basaglar Kwikpen U-10014%Lantus Solostar13%Lantus11%Part D<11 patients+ 1 more class in this area
Cardiovascular
12.3%ACE inhibitor5.7%Lisinopril100%Part D<11 patientsStatin3.7%Atorvastatin Calcium100%Part D<11 patients+ 1 more class in this area
Hormonal (systemic)
5.4%l-Thyroxine5.4%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2026 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Association Between Midpregnancy Food Intake Timing Patterns and Gestational Weight Gain
Journal of Women s Health
2025 - Associations of Sleep Health and Metabolic Syndrome Severity in Black Individuals: The Jackson Heart Sleep Study
The Journal of Clinical Endocrinology & Metabolism
2025 - Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis
Communications Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”